Liquid Biopsy to Inform Targeted Tx of Colorectal Cancer

In this video, Dr. Heinz-Josef Lenz outlines the many advantages that development of liquid biopsy is affording cancer patients.

Related Content:

ASCO Annual Meeting: Colorectal CancerColorectal Cancer

Promising Preliminary Data for KRAS G12C Inhibition With Adagrasib Are Presented for CRC

The Current Molecular Treatment Landscape of Advanced Colorectal Cancer and Need for the COLOMATE Platform

Onvansertib Plus Standard-of Care-Chemotherapy Meet Primary End Point of ORR in Metastatic Colorectal Cancer